H. Woelk et al., Benfotiamine in treatment of alcoholic polyneuropathy: An 8-week randomized controlled study (BAP I study), ALC ALCOHOL, 33(6), 1998, pp. 631-638
A three-armed, randomized, multicentre, placebo-controlled double-blind stu
dy was used to examine the efficacy of benfotiamine vs a combination contai
ning benfotiamine and vitamins Bg and Bit in out-patients with severe sympt
oms of alcoholic polyneuropathy (Benfotiamine in treatment of Alcoholic Pol
yneuropathy, BAP I). The study period was 8 weeks and 84 patients fulfilled
all the prerequisite criteria and completed the study as planned. Benfotia
mine led to significant improvement of alcoholic polyneuropathy. Vibration
perception (measured at the tip of the great toe) significantly improved in
the course of the study, as did motor function, and the overall score refl
ecting the entire range of symptoms of alcoholic polyneuropathy. A tendency
toward improvement was evident for pain and co-ordination; no therapy-spec
ific adverse effects were seen.